Patten & Patten Inc. TN decreased its position in Docusign Inc. (NASDAQ:DOCU – Free Report) by 19.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,469 shares of the company’s stock after selling 1,080 shares during the quarter. Patten & Patten Inc. TN’s holdings in Docusign were worth $348,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Hemington Wealth Management raised its holdings in Docusign by 318.1% in the first quarter. Hemington Wealth Management now owns 347 shares of the company’s stock valued at $28,000 after acquiring an additional 264 shares in the last quarter. Banque Transatlantique SA acquired a new stake in Docusign in the first quarter valued at approximately $26,000. Golden State Wealth Management LLC raised its holdings in Docusign by 519.4% in the first quarter. Golden State Wealth Management LLC now owns 384 shares of the company’s stock valued at $31,000 after acquiring an additional 322 shares in the last quarter. Summit Securities Group LLC acquired a new stake in Docusign in the first quarter valued at approximately $34,000. Finally, Rise Advisors LLC raised its holdings in Docusign by 864.6% in the first quarter. Rise Advisors LLC now owns 463 shares of the company’s stock valued at $38,000 after acquiring an additional 415 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.
Insider Buying and Selling
In other Docusign news, insider Robert Chatwani sold 13,817 shares of the business’s stock in a transaction that occurred on Wednesday, September 17th. The stock was sold at an average price of $83.10, for a total value of $1,148,192.70. Following the completion of the sale, the insider owned 71,162 shares in the company, valued at approximately $5,913,562.20. The trade was a 16.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider James P. Shaughnessy sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $71.19, for a total value of $533,925.00. Following the sale, the insider owned 55,442 shares of the company’s stock, valued at $3,946,915.98. This trade represents a 11.92% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 102,533 shares of company stock valued at $7,709,933 in the last 90 days. Company insiders own 1.01% of the company’s stock.
Docusign Trading Down 1.2%
Docusign (NASDAQ:DOCU – Get Free Report) last issued its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The company had revenue of $800.64 million during the quarter, compared to analysts’ expectations of $780.35 million. During the same quarter in the previous year, the business earned $0.97 earnings per share. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, research analysts predict that Docusign Inc. will post 1.17 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several brokerages recently weighed in on DOCU. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Docusign in a report on Wednesday, October 8th. Piper Sandler upped their price target on Docusign from $85.00 to $90.00 and gave the company a “neutral” rating in a report on Friday, September 5th. Citigroup upped their price target on Docusign from $110.00 to $115.00 and gave the company a “buy” rating in a report on Thursday, September 4th. Wells Fargo & Company upped their price target on Docusign from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Friday, September 5th. Finally, Morgan Stanley upped their price target on Docusign from $86.00 to $90.00 and gave the company an “equal weight” rating in a report on Monday, September 8th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and fifteen have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $94.14.
View Our Latest Report on Docusign
Docusign Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More
- Five stocks we like better than Docusign
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Salesforce’s Long-Awaited Inflection is Here: Rally On!
- How to Start Investing in Real Estate
- Rocket Lab USA Receives Wall Street Validation: Time to Buy?
- What Are the FAANG Stocks and Are They Good Investments?
- Archer Buys Rival’s Patent Treasure Trove in Strategic Move
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.